Emergent BioSolutions Faces Investor Revolt Over Botched Vaccines

Online-PR: … unsere digitale Pressearbeit im Internet hilft weiter… In the latest shareholder lawsuit, a pension fund accused executives at Emergent BioSolutions of insider trading. The company, under investigation by Congress, has halted manufacturing of Covid-19 vaccines at its Baltimore factory at regulators’ request.